{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:23:13Z","timestamp":1791274993030,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.molmed.2011.06.003","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T12:45:35Z","timestamp":1311425135000},"page":"625-633","source":"Crossref","is-referenced-by-count":78,"title":["mTOR signaling in polycystic kidney disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Oxana","family":"Ibraghimov-Beskrovnaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2011.06.003_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","article-title":"Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease","volume":"5","author":"Ecder","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00467-010-1656-1","article-title":"Diagnosis and management of childhood polycystic kidney disease","volume":"26","author":"Sweeney","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0025","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1590\/S0100-879X2006001200004","article-title":"Molecular and cellular pathogenesis of autosomal recessive polycystic kidney disease","volume":"39","author":"Menezes","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.molmed.2011.06.003_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.2008050456","article-title":"Nephronophthisis: disease mechanisms of a ciliopathy","volume":"20","author":"Hildebrandt","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ackd.2010.01.006","article-title":"Treatment strategies and clinical trial design in ADPKD","volume":"17","author":"Torres","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.molmed.2011.06.003_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MNH.0b013e3283262ab0","article-title":"Advances in the pathogenesis and treatment of polycystic kidney disease","volume":"18","author":"Patel","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.molmed.2011.06.003_bib0045","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1159\/000320888","article-title":"Mechanisms of nephronophthisis and related ciliopathies","volume":"118","author":"Hurd","year":"2011","journal-title":"Nephron. Exp. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm952","article-title":"Intraflagellar transport","volume":"3","author":"Rosenbaum","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/jcs.050377","article-title":"The primary cilium at a glance","volume":"123","author":"Satir","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2011.06.003_bib0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrg2774","article-title":"The primary cilium: a signalling centre during vertebrate development","volume":"11","author":"Goetz","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00467-010-1697-5","article-title":"Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms","volume":"26","author":"Gascue","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.molmed.2011.06.003_bib0075","doi-asserted-by":"crossref","first-page":"R378","DOI":"10.1016\/S0960-9822(02)00877-1","article-title":"Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease","volume":"12","author":"Pazour","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0080","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia","volume":"13","author":"Yoder","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0085","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/hmg\/ddg274","article-title":"Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia","volume":"12","author":"Ward","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0090","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrg1727","article-title":"Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease?","volume":"6","author":"Hildebrandt","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0095","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1073\/pnas.0836980100","article-title":"Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease","volume":"100","author":"Lin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.06.003_bib0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1083\/jcb.151.3.709","article-title":"Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella","volume":"151","author":"Pazour","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0105","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1681\/ASN.2006020136","article-title":"Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease","volume":"17","author":"Smith","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00232-001-0075-4","article-title":"Bending the MDCK cell primary cilium increases intracellular calcium","volume":"184","author":"Praetorius","year":"2001","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ng1552","article-title":"Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways","volume":"37","author":"Simons","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0125","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng1644","article-title":"Disruption of Bardet\u2013Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates","volume":"37","author":"Ross","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ng.105","article-title":"THM1 negatively modulates mouse sonic hedgehog signal transduction and affects retrograde intraflagellar transport in cilia","volume":"40","author":"Tran","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0070-2153(08)00809-0","article-title":"The primary cilium at the crossroads of mammalian hedgehog signaling","volume":"85","author":"Wong","year":"2008","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0070-2153(08)00810-7","article-title":"The primary cilium coordinates signaling pathways in cell cycle control and migration during development and tissue repair","volume":"85","author":"Christensen","year":"2008","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0145","doi-asserted-by":"crossref","first-page":"G725","DOI":"10.1152\/ajpgi.90265.2008","article-title":"Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors","volume":"295","author":"Masyuk","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0150","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ncb2117","article-title":"Primary cilia regulate mTORC1 activity and cell size through Lkb1","volume":"12","author":"Boehlke","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2011.06.003_bib0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2013 a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0170","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/hmg\/ddp149","article-title":"Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis","volume":"18","author":"Bonnet","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.molmed.2011.06.003_bib0175","first-page":"S119","article-title":"TSC2, a key player in tumor suppression and cystic kidney disease","volume":"2","author":"Cai","year":"2006","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.molmed.2011.06.003_bib0180","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1097-2765(01)00226-X","article-title":"Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene","volume":"7","author":"Kleymenova","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/hmg\/ddn325","article-title":"The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway","volume":"18","author":"Hartman","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0190","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1600-6143.2010.03152.x","article-title":"Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?","volume":"10","author":"Canaud","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.molmed.2011.06.003_bib0195","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.06.003_bib0200","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"Zafar","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ki.2009.147","article-title":"Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis","volume":"76","author":"Gattone","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0215","doi-asserted-by":"crossref","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","article-title":"Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR","volume":"5","author":"Dere","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2011.06.003_bib0220","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1172\/JCI41531","article-title":"Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease","volume":"120","author":"Qin","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2011.06.003_bib0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0230","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1440-1797.2007.00811.x","article-title":"Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease","volume":"12","author":"Wahl","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.molmed.2011.06.003_bib0235","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1152\/ajprenal.00129.2010","article-title":"mTORC1\/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease","volume":"300","author":"Belibi","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0240","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats","volume":"26","author":"Renken","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2011.06.003_bib0245","doi-asserted-by":"crossref","first-page":"F1597","DOI":"10.1152\/ajprenal.00430.2009","article-title":"Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease","volume":"297","author":"Wu","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0250","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4161\/cc.8.7.8044","article-title":"Targeting mTOR with rapamycin: one dose does not fit all","volume":"8","author":"Foster","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molmed.2011.06.003_bib0255","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1","volume":"29","author":"Distefano","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0260","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cellbi.2009.06.012","article-title":"Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway","volume":"33","author":"Zheng","year":"2009","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0265","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/MCB.00782-08","article-title":"Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin","volume":"29","author":"Toschi","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10334-008-0158-7","article-title":"Monitoring kidney and renal cyst volumes applying MR approaches on a rapamycin treated mouse model of ADPKD","volume":"22","author":"Reichardt","year":"2009","journal-title":"MAGMA"},{"key":"10.1016\/j.molmed.2011.06.003_bib0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease","volume":"30","author":"Wu","year":"2007","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.molmed.2011.06.003_bib0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4067\/S0716-97602009000400005","article-title":"Mycophenolate mofetil versus rapamycin in Han: SPRD rats with polycystic kidney disease","volume":"42","author":"Zhang","year":"2009","journal-title":"Biol. Res."},{"key":"10.1016\/j.molmed.2011.06.003_bib0285","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0290","first-page":"128","article-title":"Polycystic kidney disease","volume":"9","author":"Grantham","year":"2003","journal-title":"Sci. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0295","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0300","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0305","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0310","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0315","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2010.457","article-title":"mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression","volume":"79","author":"Huber","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0320","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0325","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1093\/ndt\/gfq527","article-title":"Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment","volume":"25","author":"Ponticelli","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2011.06.003_bib0330","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4155\/fmc.10.233","article-title":"Recent advances in the discovery of small molecule mTOR inhibitors","volume":"2","author":"Roychowdhury","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0335","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.mehy.2009.05.043","article-title":"Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease","volume":"73","author":"McCarty","year":"2009","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.molmed.2011.06.003_bib0340","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.06.003_bib0345","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/ndt\/gfp777","article-title":"Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD","volume":"25","author":"Leuenroth","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2011.06.003_bib0350","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0355","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0360","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0365","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0370","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11313570-000000000-00000","article-title":"Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease","volume":"23","author":"Li","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmed.2011.06.003_bib0375","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature05348","article-title":"Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine","volume":"444","author":"Bukanov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.06.003_bib0380","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4161\/cc.6.7.4047","article-title":"Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy","volume":"6","author":"Ibraghimov-Beskrovnaya","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molmed.2011.06.003_bib0385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2011.06.003_bib0390","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0395","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0400","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1681\/ASN.2007070771","article-title":"20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease","volume":"19","author":"Park","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0405","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0410","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/MCB.00072-07","article-title":"Fibrocystin\/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0415","doi-asserted-by":"crossref","first-page":"F930","DOI":"10.1152\/ajprenal.00285.2006","article-title":"Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling","volume":"292","author":"Xu","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0420","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","article-title":"Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease","volume":"10","author":"Low","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0430","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1074\/jbc.M410697200","article-title":"Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium","volume":"280","author":"Qian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0435","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1038\/sj.onc.1204825","article-title":"Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene","volume":"20","author":"Saadi-Kheddouci","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2011.06.003_bib0440","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1074\/jbc.274.8.4947","article-title":"The polycystic kidney disease 1 gene product modulates Wnt signaling","volume":"274","author":"Kim","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0445","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nm.2010","article-title":"Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy","volume":"15","author":"Lancaster","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2011.06.003_bib0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","article-title":"PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2","volume":"109","author":"Bhunia","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0455","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ncb1326","article-title":"Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2","volume":"7","author":"Li","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0460","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.cub.2005.09.012","article-title":"PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts","volume":"15","author":"Schneider","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0465","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1242\/dev.01894","article-title":"Mouse intraflagellar transport proteins regulate both the activator and repressor functions of Gli transcription factors","volume":"132","author":"Liu","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.molmed.2011.06.003_bib0470","doi-asserted-by":"crossref","first-page":"F1298","DOI":"10.1152\/ajprenal.00579.2007","article-title":"Epithelial Na+ channel activation and processing in mice lacking SGK1","volume":"294","author":"Fejes-Toth","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0475","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/chan.3.2.8086","article-title":"Serum- and glucocorticoid-inducible kinases (SGK) regulate KCNQ1\/KCNE potassium channels","volume":"3","author":"Strutz-Seebohm","year":"2009","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.molmed.2011.06.003_bib0480","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbrc.2006.11.065","article-title":"Dexamethasone increases Na+\/K+ ATPase activity in insulin secreting cells through SGK1","volume":"352","author":"Ullrich","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2011.06.003_bib0485","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1074\/jbc.M109.017756","article-title":"Polycystin-1 C-terminal cleavage is modulated by polycystin-2 expression","volume":"284","author":"Bertuccio","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0490","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.201006173","article-title":"The cell biology of polycystic kidney disease","volume":"191","author":"Chapin","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0495","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI21753","article-title":"Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1C terminus","volume":"114","author":"Chauvet","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2011.06.003_bib0500","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.06.003_bib0505","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cellsig.2006.09.005","article-title":"Cell biology of polycystin-2","volume":"19","author":"Tsiokas","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2011.06.003_bib0510","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/35050128","article-title":"Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents","volume":"408","author":"Hanaoka","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.06.003_bib0515","doi-asserted-by":"crossref","first-page":"25582","DOI":"10.1074\/jbc.M402829200","article-title":"The N-terminal extracellular domain is required for polycystin-1-dependent channel activity","volume":"279","author":"Babich","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0520","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb754","article-title":"Polycystin-2 is an intracellular calcium release channel","volume":"4","author":"Koulen","year":"2002","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0525","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0530","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0535","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/hmg\/ddm039","article-title":"Polyductin undergoes notch-like processing and regulated release from primary cilia","volume":"16","author":"Kaimori","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.06.003_bib0540","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1681\/ASN.2007070770","article-title":"Fibrocystin\/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function","volume":"19","author":"Kim","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0545","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0550","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0555","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2011.06.003_bib0560","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0565","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2011.06.003_bib0570","doi-asserted-by":"crossref","first-page":"pe27","DOI":"10.1126\/scisignal.267pe27","article-title":"New insights into mTOR signaling: mTORC2 and beyond","volume":"2","author":"Alessi","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molmed.2011.06.003_bib0575","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1\u2013TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0580","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","article-title":"Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2011.06.003_bib0585","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1083\/jcb.200507119","article-title":"Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning","volume":"173","author":"Cai","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2011.06.003_bib0590","doi-asserted-by":"crossref","first-page":"10189","DOI":"10.1074\/jbc.M210837200","article-title":"Identification of a proline-rich Akt substrate as a 14-3-3 binding partner","volume":"278","author":"Kovacina","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.06.003_bib0595","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2010.02.002","article-title":"Phosphorylation of PRAS40 on Thr246 by PKB\/AKT facilitates efficient phosphorylation of Ser183 by mTORC1","volume":"22","author":"Nascimento","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2011.06.003_bib0600","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.06.003_bib0605","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.molcel.2010.05.017","article-title":"Structure of the human mTOR complex I and its implications for rapamycin inhibition","volume":"38","author":"Yip","year":"2010","journal-title":"Mol. Cell"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411001043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411001043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T11:24:39Z","timestamp":1543663479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491411001043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":121,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1471491411001043"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2011.06.003","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}